Skip to main content

RHUMBLINE ADVISERS

Position in BMY — Bristol Myers Squibb Co

CIK 1115418 BOSTON, MA

Position in BMY

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$221,224,999
+$28,120,285 QoQ
Shares Held
3,647,568
+1.9% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 58.477319682593986.ToString("F0")% Shared 0.ToString("F0")% None 41.52268031740601.ToString("F0")%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $4,442,669,348 across 18 Drug Manufacturers - General names. BMY ranks #8 (5.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 BMY
Bristol Myers Squibb Co
This page
3,647,568 $221,224,999

All Filings in BMY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $221,224,999 3,647,568
2025-12-31 $193,104,714 3,579,991
2025-09-30 $165,280,991 3,664,767
2025-06-30 $175,600,605 3,793,489
2025-03-31 $216,328,053 3,546,943
2024-12-31 $206,683,475 3,654,234
2024-09-30 $190,683,061 3,685,409
2024-06-30 $158,652,116 3,820,181
2024-03-31 $204,626,004 3,773,299
2023-12-31 $193,525,413 3,771,690
2023-09-30 $228,905,987 3,943,935
2023-06-30 $254,165,757 3,974,445
2023-03-31 $271,762,014 3,920,964
2022-12-31 $278,672,279 3,873,138
2022-09-30 $263,545,629 3,707,211
2022-06-30 $278,128,389 3,612,057
2022-03-31 $257,304,189 3,523,267
2021-12-31 $221,882,700 3,558,664
2021-09-30 $207,681,848 3,509,918
2021-06-30 $243,862,931 3,649,550
2021-03-31 $244,476,227 3,872,584
2020-12-31 $249,611,449 4,024,044
2020-09-30 $243,954,381 4,046,349
2020-06-30 $238,484,685 4,055,862
2020-03-31 $221,222,751 3,968,833